Vanqua Bio’s Post

May is ALS Awareness Month, dedicated to raising awareness about Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease. Despite the challenges posed by ALS, there is hope. Through increased awareness and advancements in research, we can work towards finding effective treatments and ultimately, a cure for this debilitating disease. This month, let's come together to support those affected by ALS and renew our commitment to fighting for a world free from ALS. #ALS #HopeForACure

World Multiple Sclerosis Day 🧠🌍 Today, we stand together to raise awareness about Multiple Sclerosis (MS), a chronic autoimmune disease affecting millions worldwide. Let’s amplify the voices of those living with MS and support ongoing research to find better treatments and, ultimately, a cure. Remember, every step we take brings us closer to understanding and conquering this condition. #multiplesclerosis #autoimmunedisease #chronicdisease

🌎 On World IBD Day, May 19, we recognize the millions of people worldwide living with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. These chronic conditions bring immense pain and suffering, yet there is no cure and little understanding of their impact. Today, we honor not only the patients but also the dedicated researchers 🔬 working tirelessly to develop groundbreaking therapies to improve lives. #IBDhasnoborders #worldibdday2024 #IBD #Research #DDW2014

May is #CIDPAwarenessMonth. CIDP, or chronic inflammatory demyelinating polyneuropathy, is a rare disease with less than 2 in 100,000 cases reported each year. CIDP affects the peripheral nervous system, which is responsible for sending critical information between the brain and body. Treatment options are limited for this autoantibody disease. At J&J, our researchers are pushing the boundaries of science towards new solutions that leverage our rapidly expanding understanding of the underlying cause of autoantibody diseases. We hope to one day lead the way in delivering innovative and transformational treatments for people living with CIDP. 

Today is Rare Disease Day, a globally recognized campaign dedicated to raising awareness and generating change for the 300 million people worldwide living with a rare disease. Many of our clients are focused on developing treatments to help the lives of patients with a rare disease. Recently, we mapped the patient journey for an ultra-rare disease impacting <5 K patients in the U.S., which affects the body's ability to metabolize cholesterols and leads to progressive neurological problems. A potentially lifesaving therapy already existed, but the disease is significantly underdiagnosed, so our team helped our client devise a strategy to raise disease awareness and find/diagnose new patients. We love that we’re able to support our clients to make such an impact on people’s lives. #rarediseaseday #patientimpact #clearviewhcp #YourFutureisinClearView #lifesciences

Parkinson’s disease often starts with a tremor in a finger, muscle stiffness, or slowness of movements, often on one side of the body. These are signs of an abnormality in a part of the brain that controls mobility, which will worsen over time. Nobody knows how the disease will progress in an individual - some people will have mild symptoms that worsen very slowly but never become severe, while many others will develop difficulties with walking and speaking, cognitive issues, and other life-changing problems. “The problem with Parkinson’s disease is that it alters how people interact with the world around them - and the confidence they have in being themselves,” says Veronica Santini, MD, MA, director of the Adams Comprehensive Parkinson’s Disease Care Center at Yale, who works with the disease both as a clinician and a researcher. “Our definitive goal for this disease is, eventually, to be able to stop or slow down its progression. We want to help patients go back to feeling comfortable in the world that they love and be the people they want to be.” Although promising research is expected to have an impact on patients’ lives in the years to come, there is currently no cure for Parkinson’s disease. Newly diagnosed patients, however, want to know how to manage their condition now. Read about managing Parkinson's disease here: https://brnw.ch/21wNaCs #parkinsonsdisease #pd #parkinsons

Could you identify the early hints of amyotrophic lateral sclerosis (ALS)? Also called Lou Gehrig’s disease, amyotrophic lateral sclerosis signs start as limb weakness that ultimately progresses to loss of bodily function. Discover what to watch out for in this article: https://bit.ly/3OeNV9b

🌟 March is Autoimmune Disease Awareness Month, and it's time to shine a light on spondyloarthritis—a group of inflammatory diseases that primarily affect the spine and other joints. 🩻💪 This month, we're diving deep into understanding the complexities of spondyloarthritis, its impact, and the importance of early diagnosis and comprehensive care. Join us in spreading awareness and empathy for those navigating life with spondyloarthritis and other autoimmune diseases. Together, we can foster a world of greater understanding and support for everyone affected. 💖 #AutoimmuneDiseaseAwareness #Spondyloarthritis #AwarenessMonth #SupportAndEducate

📢 Exciting new Lyme disease research! 🧬 Tufts University are launching one of the largest studies ever into chronic Lyme disease, funded by a $20.7 million National Institutes of Health (NIH) grant, to uncover why some people experience persistent symptoms even after treatment. This groundbreaking research which will recruit 1,000 patients over five years, aims to finally answer long-standing questions about chronic Lyme disease, and could lead to better diagnosis and treatment options. 👉 Learn more: https://lnkd.in/gA6sFiXC #LymeDisease #LymeResearch #ChronicLyme #LymeAwareness

Most of us know someone close to us who suffers from Parkinson’s. Did you know that more than 10 million people worldwide are impacted from this debilitating disease, and men are 50 percent more likely to develop Parkinson’s? Current therapies only provide symptomatic relief. At Bayer, we remain committed to advancing #CellTherapy and #GeneTherapy, that has the potential to transform the lives of people with Parkinson's disease. #TeamBayer #HealthForAllHungerForNone #WorldParkinsonsDay